Appendix A Benefits and limitations of types of passive surveillance data for antimicrobial use Data type Data sources Benefits Limitations (number of software systems) Amount prescribed Electronic prescribing Can link to clinical data No standardised data systems (>10) (e.g. indication) structures or reports Ability to use data to Stand-alone systems not influence prescriber centrally linked decision. More than 95% Not uniformly used for of GPs used these prescribing in Australia systems Manual prescription Enables assessment of Manual data collection is chart audit (0) clinical appropriateness time intensive and not and context ongoing NPS MedicineInsight Will provide data from Rollout is currently (1) 300 representative ongoing GP No AU reports yet practices Link to reason for use and pathology test orders data (1) Data from 100 Not an ongoing data consecutive system consultations with 1000 Antimicrobial prescribing representative GPs is not routinely surveyed Amount dispensed Statewide hospital Extensive tracking of all Only in hospitals and pharmacy dispensing hospital dispensing only in some states systems (ACT, NT, procurement and supply Unable to report stock Qld, SA, Tas) (1) Data fields standardised supplied on imprest (i.e. within each state (e.g. stored on ward for iPharmacy feeds all Qld general use) use data to MedTRx) Hospital pharmacy Extensive tracking of all Stand-alone systems not systems (NSW, Vic, hospital dispensing centrally linked WA) (>3) procurement and supply Hospital data not standardised Community Extensive tracking of all Stand-alone systems not pharmacy dispensing community dispensing centrally linked systems (>10) procurement and supply including RACFs and – private hospitals serviced by the community pharmacy
Appendix A Benefits and limitations of types of passive surveillance data for antimicrobial use Data type Data sources (number of software systems) Benefits Limitations Amount prescribed Electronic prescribing systems (>10) Can link to clinical data (e.g. indication) Ability to use data to influence prescriber decision. More than 95% of GPs used these systems No standardised data structures or reports Stand-alone systems not centrally linked Not uniformly used for prescribing in Australia Manual prescription chart audit (0) Enables assessment of clinical appropriateness and context Manual data collection is time intensive and not ongoing NPS MedicineInsight (1) Will provide data from 300 representative GP practices Link to reason for use and pathology test orders Rollout is currently ongoing No AU reports yet data (1) Data from 100 consecutive consultations with 1000 representative GPs Not an ongoing data system Antimicrobial prescribing is not routinely surveyed Amount dispensed Statewide hospital pharmacy dispensing systems (ACT, NT, Qld, SA, Tas) (1) Extensive tracking of all hospital dispensing procurement and supply Data fields standardised within each state (e.g. iPharmacy feeds all Qld use data to MedTRx) Only in hospitals and only in some states Unable to report stock supplied on imprest (i.e. stored on ward for general use) Hospital pharmacy systems (NSW, Vic, WA) (>3) Extensive tracking of all hospital dispensing procurement and supply Stand-alone systems not centrally linked Hospital data not standardised Community pharmacy dispensing systems (>10) Extensive tracking of all community dispensing procurement and supply – including RACFs and private hospitals serviced by the community pharmacy Stand-alone systems not centrally linked
AURA-Preliminary-Report-Highlights-Doc-Dec-2015-Wed.docx